Medicare Benefits Schedule - Note IR.1.1

1. For any particular patient, item 55143 applies to a service if:

1. the service is for an exercise stress echocardiography and includes all of the following:
   1. two-dimensional recordings before exercise (baseline) from at least 2 acoustic windows; and
   2. matching recordings at or immediately after peak exercise, which include at least parasternal short and long axis views, and apical 4-chamber and 2 chamber views; and
   3. recordings on digital media with equipment permitting display of baseline and matching peak images on the same screen; and
   4. resting electrocardiogram and continuous multi-channel electrocardiogram monitoring and recording during stress; and
   5. blood pressure monitoring and the recording of other parameters (including heart rate); or
2. the service is for a pharmacological stress echocardiography and includes all of the following:
   1. two-dimensional recordings before drug infusion (baseline) from at least 2 acoustic windows; and
   2. matching recordings at least twice during drug infusion, including a recording at the peak drug dose, which include at least parasternal short and long axis views, and apical 4-chamber and 2 chamber views; and
   3. recordings on digital media with equipment permitting display of baseline and matching peak images on the same screen; and
   4. resting electrocardiogram and continuous multi-channel electrocardiogram monitoring and recording during stress; and
   5. blood pressure monitoring and the recording of other parameters (including heart rate).

Related Items: 55143

• Previous - Note IR.0.1
• Next - Note IR.1.2

Bulk bill incentive

Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.0.1, IR.1.1 and IR.1.2 

Repeat pharmacological or exercise stress echocardiography if:

(a) a service to which item 55141, 55145, 55146, or this item, applies has been performed on the patient in the previous 24 months; and

(b) the patient has symptoms of ischaemia that have evolved and are not adequately controlled with optimal medical therapy; and

(c) the service is requested by a specialist or a consultant physician; and

(d) the service is not associated with a service to which:

(i) item 11704, 11705, 11707, 11714, 11729 or 11730 applies; or

(ii) an item in Subgroup 3 applies

Applicable not more than once in a 12 month period (R)

Fee: $445.55 Benefit: 75% = $334.20 85% = $378.75

(See para IN.0.19, IN.1.10, IR.0.1, IR.1.1, IR.1.2, IR.1.3 of explanatory notes to this Category)